Archives

img-01

Japan Slides Off the Patent Cliff

Japan’s looming ‘patent cliff’ has analysts wondering what Japanese pharmaceutical companies will do in an attempt to offset revenue losses when their blockbuster patents expire over the next few years. The ‘patent cliff’ phenomenon that began in 2009 is expected to peak... Read More

img-01

Japan Issues Minor Changes to FMA Application

On October 8, 2010, the Pharmaceuticals and Medical Device Agency (PMDA) of Japan’s Ministry of Health, Labour and Welfare (MHLW) released Notification 1008 No. 1. With this notification, marketing authorization holders (MAHs) who are involved in the foreign manufacturer accreditation (FMA) process... Read More

img-01

Japan’s Reimbursement Regulatory Update

In April 2010, Japan officially updated its reimbursement prices. The complete details of this update were released on the Ministry of Health, Labour and Welfare (MHLW) website on September 1, 2010. This update has led to an overall net positive 0.19% change... Read More

img-01

Diabetes Explosion in Asia

Asia's cases of diabetes are at an all-time high. The International Diabetes Federation (IDF) estimates that more than 125 million people in Asia are suffering from the condition this year. These numbers are climbing quickly. There likely will be more than 200... Read More

img-01

Device Companies Look to Asia for Growth

Introduction With the United States emerging very slowly from a huge recession, some of Europe unable to pay its bills, and more restrictions coming from the US Food and Drug Administration (FDA), an area where medical device companies may want to focus... Read More

img-01

Medical Product Harmonization Meeting in Japan

Japan recently hosted the APEC Life Sciences Innovation Forum (LSIF) Regulatory Harmonization Steering Committee (RHSC) meeting on March 2-4, 2010. RHSC was established in 2008 to promote a strategic and coordinated approach to regulatory harmonization and capacity building efforts within the APEC... Read More